Digital Therapeutics Market Set to Reach US$19.76 Billion by 2035

The global digital therapeutics market is projected to grow from US$2.83 billion in 2024 to US$19.76 billion by 2035, reflecting a compound annual growth rate (CAGR) of 19.32%, according to a new report published by ResearchAndMarkets.

Digital therapeutics, software-driven tools designed to prevent, manage, or treat medical conditions, are gaining traction, particularly in areas where traditional pharmacological interventions fall short, such as chronic illnesses and mental health disorders. The rise of standalone software applications, which now make up over 45% of available or in-development solutions, signals the market’s shift toward scalable, patient-centered digital care models.

Software solutions dominate the sector, with curative applications leading over preventive ones. Medication replacement tools are also poised to maintain a strong market share, reads the study, although medical augmentation solutions are forecasted to grow at a faster pace.

The business-to-business (B2B) model accounts for most digital therapeutics offerings, often targeting hospitals, payers, and employers. Hospitals are beginning to roll out staff education programs to boost digital literacy and adoption of these tools, an effort that may help address one of the industry’s key bottlenecks.

“Future doctors must be prepared to guide patients who use these technological tools and assess if their assessment is clinically valid. If doctors are not equipped to understand these tools, they cannot properly guide patients in this new era of medicine,” says Sebastián Prida, CEO, Medu, to MBN.

Metabolic disorders remain the top target for digital therapeutics, followed closely by cardiovascular disease, mental health, and neurological disorders. The report highlights that neurological applications are expected to grow significantly, suggesting a broader integration of digital therapeutics into cognitive and behavioral health strategies. 

Mental health solutions are becoming increasingly relevant in countries like Mexico, where 3.6 million adults suffer from depression, with 1% of cases classified as severe, according to a study by the Psychiatric Care Services (SAP) of the Ministry of Health (SSA).

Regionally, North America leads in market share, fueled by tech innovation, regulatory support, and high digital engagement. However, Asia is expected to see the highest growth rate over the coming decade as local players scale up and digital health awareness spreads.

Despite concerns over digital literacy among both patients and providers, the market outlook remains positive. Growing governmental and private-sector investment in digital health, along with technological advances and greater patient demand for non-invasive, remote, and personalized care, is positioning digital therapeutics as a core pillar of modern healthcare.